Home Biosimilar Antibodies Protein Tyrosine Kinase Others antibody Cofetuzumab (Anti-PTK7 / CCK4) For research use only.
Not for use in humans.

Cofetuzumab (Anti-PTK7 / CCK4)

Synonyms: null

Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.

Cofetuzumab (Anti-PTK7 / CCK4)

Purity & Quality Control

Batch: A280301 Purity: 99% Protein concentration: 6.05mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.

Product Details

CAS No. 1869928-62-0
Molecular Weight 146.7
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) supplier | purchase Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) cost | Cofetuzumab (Anti-PTK7 / CCK4) manufacturer | order Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) distributor